(Q54574020)

1 June 2018

title

Cytokine gene expression patterns associated with immunization against Marek's disease in chickens. (English)

1 reference

1 June 2018

0 references

6

Shayan Sharif

1 reference

1 June 2018

author name string

Mohamed Faizal Abdul-Careem

1

1 reference

1 June 2018

Bruce D Hunter

2

1 reference

1 June 2018

Payvand Parvizi

3

1 reference

1 June 2018

Hamid R Haghighi

4

1 reference

1 June 2018

Niroshan Thanthrige-Don

5

1 reference

1 June 2018

language of work or name

English

0 references

publication date

22 August 2006

1 reference

1 June 2018

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

1 June 2018

volume

25

1 reference

1 June 2018

issue

3

1 reference

1 June 2018

page(s)

424-432

1 reference

1 June 2018

Development of a real-time PCR assay using SYBR Green chemistry for monitoring Marek's disease virus genome load in feather tips

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Marek's disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

The Leeuwenhoek Lecture, 1997. Marek's disease herpesvirus: oncogenesis and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

The immunologists' debt to the chicken

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Early cell-mediated immune responses to Marek's disease virus in two chicken lines with defined major histocompatibility complex antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Biocharacteristics shared by highly protective vaccines against Marek's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

IL-18 stimulates the proliferation and IFN-gamma release of CD4+ T cells in the chicken: conservation of a Th1-like system in a nonmammalian species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Enhancement of natural killer cell activity by Marek's disease vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Absolute quantitation of Marek's disease virus and Herpesvirus of turkeys in chicken lymphocyte, feather tip and dust samples using real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Applications in in ovo technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Pro-inflammatory responses in chicken spleen and brain tissues after infection with very virulent plus Marek's disease virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Chicken industry strategies for control of tumor virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Titration of Marek's disease cell-associated vaccine virus (CVI 988) of reconstituted vaccine and vaccine ampoules from Dutch hatcheries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Re-isolation of Marek's disease virus from T cell subsets of vaccinated and non-vaccinated chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Nickel-induced IL-10 down-regulates Th1- but not Th2-type cytokine responses to the contact allergen nickel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Pathogenesis of Marek's disease (MD) and possible mechanisms of immunity induced by MD vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Anti-viral and anti-tumor effects induced by an attenuated Marek's disease virus in CD4- or CD8-deficient chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Protection against Marek's Disease by Vaccination with a Herpesvirus of Turkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Marek's disease virus: from miasma to model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Cloning and characterization of chicken IL-10 and its role in the immune response to Eimeria maxima

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Characterisation of two highly oncogenic strains of Marek's disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Absence of age-resistance in neonatally thymectomised chickens as evidence for cell-mediated immune surveillance in Marek's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

Meq: an MDV-specific bZIP transactivator with transforming properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.08.006

1 reference

1 June 2018

1 reference

1 June 2018